Business
Announcement on Termination of Drug Clinical Trial of Subsidiary
Announcement on Termination of Drug Clinical Trial of Subsidiary
About this update from Beijing Tiantan Biological Products Corporation Limited Class A
Announcement on Termination of Drug Clinical Trial of SubsidiaryThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment